193 related articles for article (PubMed ID: 20424130)
1. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
3. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
4. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
5. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.
Steinbrecher A; Méplan C; Hesketh J; Schomburg L; Endermann T; Jansen E; Akesson B; Rohrmann S; Linseisen J
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2958-68. PubMed ID: 20852007
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism.
Jablonska E; Gromadzinska J; Sobala W; Reszka E; Wasowicz W
Eur J Nutr; 2008 Feb; 47(1):47-54. PubMed ID: 18239845
[TBL] [Abstract][Full Text] [Related]
7. Variation in selenoenzyme genes and prostate cancer risk and survival.
Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
[TBL] [Abstract][Full Text] [Related]
8. SLC30A3 and SEP15 gene polymorphisms influence the serum concentrations of zinc and selenium in mature adults.
da Rocha TJ; Korb C; Schuch JB; Bamberg DP; de Andrade FM; Fiegenbaum M
Nutr Res; 2014 Sep; 34(9):742-8. PubMed ID: 25249019
[TBL] [Abstract][Full Text] [Related]
9. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
Ekoue DN; Ansong E; Liu L; Macias V; Deaton R; Lacher C; Picklo M; Nonn L; Gann PH; Kajdacsy-Balla A; Prins GS; Freeman VL; Diamond AM
Prostate; 2018 Mar; 78(4):279-288. PubMed ID: 29314169
[TBL] [Abstract][Full Text] [Related]
10. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
Geybels MS; van den Brandt PA; Schouten LJ; van Schooten FJ; van Breda SG; Rayman MP; Green FR; Verhage BA
J Natl Cancer Inst; 2014 Mar; 106(3):dju003. PubMed ID: 24563517
[TBL] [Abstract][Full Text] [Related]
11. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
12. Association of the selenoprotein 15-kDa (
Pabalan N; Tharabenjasin P; Natphopsuk S; Ekaratcharoenchai N; Jarjanazi H
Nutr Cancer; 2020; 72(8):1297-1306. PubMed ID: 31665936
[TBL] [Abstract][Full Text] [Related]
13. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
Outzen M; Tjønneland A; Hughes DJ; Jenab M; Frederiksen K; Schomburg L; Morris S; Overvad K; Olsen A
Int J Cancer; 2021 Feb; 148(4):876-883. PubMed ID: 32838475
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
Méplan C; Rohrmann S; Steinbrecher A; Schomburg L; Jansen E; Linseisen J; Hesketh J
PLoS One; 2012; 7(11):e48709. PubMed ID: 23133653
[TBL] [Abstract][Full Text] [Related]
15. Role of SEP15 Gene Polymorphisms in the Time of Progression to AIDS.
Benelli JL; de Medeiros RM; Matte MC; de Melo MG; de Matos Almeida SE; Fiegenbaum M
Genet Test Mol Biomarkers; 2016 Jul; 20(7):383-7. PubMed ID: 27228552
[TBL] [Abstract][Full Text] [Related]
16. The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.
Watrowski R; Castillo-Tong DC; Fabjani G; Schuster E; Fischer M; Zeillinger R
Tumour Biol; 2016 Jan; 37(1):1009-15. PubMed ID: 26264612
[TBL] [Abstract][Full Text] [Related]
17. The study on polymorphisms of Sep15 and TrxR2 and the expression of AP-1 signaling pathway in Kashin-Beck disease.
Wu R; Zhang R; Xiong Y; Sun W; Li Y; Yang X; Liu J; Jiang Y; Guo H; Mo X; Cao J
Bone; 2019 Mar; 120():239-245. PubMed ID: 29653292
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
[TBL] [Abstract][Full Text] [Related]
19. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
[TBL] [Abstract][Full Text] [Related]
20. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Chan JM; Oh WK; Xie W; Regan MM; Stampfer MJ; King IB; Abe M; Kantoff PW
J Clin Oncol; 2009 Aug; 27(22):3577-83. PubMed ID: 19528373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
